Rating History for BioCryst Pharma (BCRX) by BofA/Merrill Lynch
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/23/2010 | N/A | Downgrade | Underperform (N/A) |
N/A (N/A) |
5.14 (2.52) |
-50.97% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/23/2010 | N/A | Downgrade | Underperform (N/A) |
N/A (N/A) |
5.14 (2.52) |
-50.97% | Details |
